InMed Pharmaceuticals: Pushing Pharma Forward With Rare Cannabinoids
Benzinga
Benzinga
  • last year
InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. -InMed Pharmaceuticals
Recommended
0:40
I
Up next
[READ] Continuous Manufacturing of Pharmaceuticals (Advances in Pharmaceutical Technology)
srinavniklaus
0:49
Third Party Manufacturing Company in India | Primus Pharmaceuticals
Primus Pharmaceuticals
0:34
Development and Manufacture of Protein Pharmaceuticals Review
dm_ea65da1c0dabae58b824527ec4f0bb10
2:25
DOST: Pilipinas, posible nang makapag-produce ng sariling bakuna sa huling bahagi ng 2022; pagtatayo ng vaccine manufacturing facility ng ilang local pharmaceutical companies, pinabibilis na
PTVPhilippines
Benzinga
0:36
Arizona Republicans Fail to Block Repeal as House Votes to End Near-Total Abortion Ban
Benzinga
0:35
US Secretly Provides Long-Range Missiles to Ukraine, Responding to Russian Threats
Benzinga
0:43
Microsoft-Backed Rubrik Surpasses Expectations with IPO Pricing at $32 per Share
Benzinga
0:46
TikTok Suspends 'TikTok Lite' Rewards Program in Europe After Antitrust Investigation
Benzinga
0:37
Tesla Gives Sneak Peek of Robotaxi Ride-Hailing App in First-Quarter Shareholder Deck
Benzinga
0:36
Tesla Stock Soars 12% as Elon Musk Promises More Affordable Electric Vehicles
Benzinga
Featured channels
More from
EarthX
More from
TIME
More from
Insider
More from
What's Trending
More from
Entrepreneur
More from
SportsGrid